Placemark Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$15.8M Buy
141,318
+13,483
+11% +$1.42M 0.28% 82
2014
Q3
$12.1M Buy
127,835
+27,471
+27% +$2.48M 0.22% 102
2014
Q2
$8.62M Sell
100,364
-8,372
-8% -$637K 0.15% 156
2014
Q1
$7.59M Sell
108,736
-29,224
-21% -$2.31M 0.15% 155
2013
Q4
$11.7M Sell
137,960
-6,420
-4% -$508K 0.19% 121
2013
Q3
$11.1M Buy
144,380
+3,610
+3% +$253K 0.21% 111
2013
Q2
$8.23M Buy
+140,770
New +$8.47M 0.18% 149

Other funds holding CELG

Placemark Investments's CELG Position: Q4 2014 in Review

Placemark Investments increased its Celgene Corp (CELG) stake by 11% in Q4 2014, buying an estimated $1.42M and bringing the position to 141,318 shares worth $15.8M. The position accounts for 0.28% of the portfolio, ranked #82.

Placemark Investments first reported a position in CELG in Q2 2013 and has held it in 7 quarters since. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Placemark Investments held 141,318 shares of Celgene Corp worth $15.8M as of Q4 2014.
  • Placemark Investments bought 13,483 Celgene Corp shares in Q4 2014, an estimated $1.42M.
  • Celgene Corp made up 0.28% of Placemark Investments's portfolio in Q4 2014, its #82 holding.
  • Placemark Investments first reported a position in Celgene Corp in Q2 2013 and has held it in 7 quarters since.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.